DELOS CAPITAL
Delos Capital is a lower-middle market private equity investment firm based in New York City. The Fund was formed in 2013 to invest in complex processes through Control Buyouts, Strategic Partnerships and Distressed Buyouts in companies with EBITDA of $10 – $30 million.
DELOS CAPITAL
Industry:
Finance Financial Services Venture Capital
Founded:
2013-01-01
Status:
Active
Contact:
(212) 257-4450
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Euro Microsoft Exchange Online Amazon Office 365 Mail
Similar Organizations
Color Capital
Color Capital invests in things people buy, and how they buy them.
Correlation Ventures
Correlation Ventures finances early, seed, and later stage venture, and debt financing investments and is based in California.
Techstars Anywhere Accelerator
Techstars Anywhere is provides a full Techstars program through a virtual accelerator experience.
UpWest
UpWest is a seed fund investing in Israel’s most promising entrepreneurs targeting the US market.
Current Employees Featured
Sanjay Sanghoee CFO/COO @ Delos Capital
CFO/COO
Matt Constantino Founding Partner @ Delos Capital
Founding Partner
Tim Xiao Partner @ Delos Capital
Partner
2014-12-01
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-29 | Pioneer Recycling Services | Pioneer Recycling Services acquired by Delos Capital | N/A |
| 2018-07-31 | HOP Energy | HOP Energy acquired by Delos Capital | N/A |
| 2018-03-13 | Sage Metals Ltd. | Sage Metals Ltd. acquired by Delos Capital | N/A |
| 2015-01-06 | FCA Packaging | FCA Packaging acquired by Delos Capital | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-12-09 | OncoMyx Therapeutics | Delos Capital investment in Series B - OncoMyx Therapeutics | 50 M USD |
| 2021-12-08 | Viron Inc. | Delos Capital investment in Series B - Viron Inc. | 50 M USD |
| 2021-07-15 | Imperative Care | Delos Capital investment in Series D - Imperative Care | 260 M USD |
| 2021-05-26 | LifeQ | Delos Capital investment in Series A - LifeQ | 47 M USD |
| 2021-05-07 | Phanes Therapeutics | Delos Capital investment in Series B - Phanes Therapeutics | 40 M USD |
| 2021-02-22 | Clover Biopharmaceuticals | Delos Capital investment in Series C - Clover Biopharmaceuticals | 230 M USD |
| 2020-09-14 | Rejoni | Delos Capital investment in Series A - Rejoni | 15 M USD |
| 2019-12-10 | Imperative Care | Delos Capital investment in Series C - Imperative Care | 86 M USD |
| 2019-11-27 | Clover Biopharmaceuticals | Delos Capital investment in Series B - Clover Biopharmaceuticals | 304 M CNY |
| 2019-06-06 | Viron Inc. | Delos Capital investment in Series A - Viron Inc. | 25 M USD |
More informations about "Delos Capital"
Biotech Venture Capital Firm | Delos Capital
Delos Capital. Approach. Team. Portfolio. News. Contact. We empower life sciences leaders to turn bold ideas into medical breakthroughs. driving impact. Our team draws upon diverse skills and a global network to support ground …See details»
Delos Capital - Crunchbase Investor Profile
Delos Capital is a lower-middle market private equity investment firm based in New York City. The Fund was formed in 2013 to invest in complex processes through Control Buyouts, Strategic Partnerships and Distressed Buyouts in …See details»
Expert Biotech Investment Team| Delos Capital
Delos Capital. Approach. Team. Portfolio. News. Contact. Team We are a partnership comprised of seasoned entrepreneurs and scientists, committed to investing our time and capital into a positive and lasting impact on human …See details»
A private equity firm based in New York City - Delos Capital
Matt Constantino is Managing Partner of Delos Capital and has more than 25 years of experience working with management teams, CEOs and boards of privately-held businesses. Previously, …See details»
Delos Capital - Investments, Portfolio & Company Exits - Crunchbase
Delos Capital 's most notable exits include Zenas BioPharma, Syndax Pharmaceuticals, and Clover Biopharmaceuticals. Which industries has this organization had the most exits in? …See details»
Delos Capital - Craft
Delos Capital is a private equity firm that provides investment and financial advisory services. It offers restructuring, mergers and acquisitions (M&A), and financing transaction services. The …See details»
Delos Capital Announces Formation of Financial Advisory Group …
Jul 9, 2024 Delos Capital is a private equity and financial advisory firm based in New York. We draw upon our experience having invested in and advised on some of the largest and most …See details»
Delos Capital investment portfolio - PitchBook
Delos Capital General Information Company Description. Founded in 2013, Delos Capital is a private equity firm based in New York, New York. The firm prefers to invest in lower middle …See details»
Delos Capital | 投资机构信息-36氪
Delos Capital（康禧全球投资基金）是一家以医疗为重点的基金，投资于大中华地区的增长平台以及美国在治疗和医疗技术领域的相关创新。Delos Capital寻求通过支持这些公司的发展来实现 …See details»
Delos Capital - Crunchbase Investor Profile
Delos Capital is a healthcare-focused fund, investing in growth platforms and relevant innovation in both therapeutic and medical technology areas. Delos Capital seeks to achieve returns by supporting these companies in their …See details»
Delos Capital - Private Equity Investments & Executives
Delos Capital. 120 Fifth Avenue, Third Floor. New York, New York. United States (212) 257-4450. https://www.deloscap.comSee details»
Biotech Investment Process| Delos Capital
Delos Capital. Approach. Team. Portfolio. News. Contact. Approach Our rigorous investment process combines a deep understanding of biology, unmet needs in medicine, and building …See details»
Delos Capital - Funding, Financials, Valuation & Investors
Delos Capital has raised 2 funds, their latest being Delos Investment Fund II. This fund was announced on Apr 6, 2018 and raised a total of . obfuscated. obfuscated. Announced Date . …See details»
Delos Capital Announces Formation of Financial Advisory Group …
Jul 9, 2024 Delos Capital is a private equity and financial advisory firm based in New York. We draw upon our experience having invested in and advised on some of the largest and most …See details»
Biotechnology Investment Portfolio | Delos Capital
Delos Capital. Approach. Team. Portfolio. News. Contact. Portfolio Companies Our investments are partnerships. We support visionary entrepreneurs with our capital and deep life sciences …See details»
Delos Capital - LinkedIn
Delos Capital is a life sciences investment firm. Our team draws upon diverse skills and a global network to support ground-breaking innovations that will improve lives around the world. Our ...See details»
Delos Capital Announces $300 Million First Close of its Third Life ...
HONG KONG, Feb. 15, 2022 /PRNewswire/ -- Delos Capital, a Hong Kong-headquartered life sciences venture capital fund with a global presence and investment mandate, announces the …See details»
Corporate capital Delaware is changing its law in fight pitting ...
8 hours ago Delaware lawmakers put aside protests from major investors and approved fast-tracked legislation Tuesday night that backers say will protect its status as the corporate …See details»
Delos Capital Announces $300 Million First Close of its Third Life ...
HONG KONG, Feb. 15, 2022 /PRNewswire/ — Delos Capital, a Hong Kong-headquartered life sciences venture capital fund with a global presence and investment mandate, announces the …See details»
Delos Capital - Contacts, Employees, Board Members ... - Crunchbase
Delos Capital has 3 current employee profiles, including CFO/COO Sanjay Sanghoee. Contacts. Edit Contacts Section. Job Department. Protected Content. Chief Financial Officer. Non …See details»